HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 75 filers reported holding HUMACYTE INC in Q2 2023. The put-call ratio across all filers is 45.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,299,409 | +11.0% | 1,126,078 | +8.4% | 0.00% | – |
| Q2 2023 | $2,972,341 | +45.6% | 1,039,280 | +57.3% | 0.00% | – |
| Q1 2023 | $2,041,857 | -1.5% | 660,795 | -32.7% | 0.00% | – |
| Q4 2022 | $2,071,956 | +51.8% | 981,970 | +134.6% | 0.00% | – |
| Q3 2022 | $1,365,000 | +1.7% | 418,613 | +0.1% | 0.00% | – |
| Q2 2022 | $1,342,000 | -21.2% | 418,042 | +73.3% | 0.00% | – |
| Q1 2022 | $1,703,000 | +237.2% | 241,203 | +246.2% | 0.00% | – |
| Q4 2021 | $505,000 | – | 69,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,613,000 | 3.70% |
| Monashee Investment Management LLC | 399,910 | $2,899,000 | 0.72% |
| Endowment Wealth Management, Inc. | 96,618 | $700,000 | 0.71% |
| Gladstone Institutional Advisory LLC | 246,717 | $1,789 | 0.14% |
| Diameter Capital Partners LP | 300,338 | $2,177,000 | 0.13% |
| CenterBook Partners LP | 23,706 | $172,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 900,100 | $6,526,000,000 | 0.06% |
| Exos Asset Management LLC | 16,139 | $117,000 | 0.06% |
| Maven Securities LTD | 200,000 | $1,450,000 | 0.04% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 11,000 | $80,000 | 0.04% |